Innospec Inc (IOSP)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NASDAQ
Market Cap: $1.98B
Last updated: Nov 17, 2026 at 11:06 AM ET
Innospec Inc (IOSP) Stock Forecast
Analysts expect Innospec (IOSP) to earn $5.04 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.91B. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 33.3% |
| Buy | 2 | 66.7% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 18.5% and revenue estimates rise 5.8%.
- Fiscal year ending Dec 31, 2026
- $5.04
- EPS consensus, revenue $1.91B
- Fiscal year ending Dec 31, 2027
- $5.97
- EPS consensus, revenue $2.02B
- Next report
- Feb 15, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $5.04 | $5.00 to $5.08 | 3 | $1.91B | $1.90B to $1.93B | 3 |
| Dec 31, 2027 | $5.97 | $5.85 to $6.10 | 3 | $2.02B | $2.00B to $2.05B | 3 |
Quarterly Estimates
The EPS consensus falls from $1.45 for the quarter ending Dec 31, 2026 to $1.40 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.45 | $1.35 to $1.52 | 5 | $505.99M | $472.36M to $534.77M | 5 |
| Mar 31, 2027 | $1.40 | $1.39 to $1.41 | 2 | $497.50M | $491.90M to $503.10M | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 2.0% from $4.94.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $5.04 | $4.92 | $4.94 | $4.94 | $4.94 | +2.2% |
| Fiscal year ending Dec 31, 2027 | $5.97 | $6.17 | $6.15 | $6.15 | $6.15 | -2.9% |
| Quarter ending Mar 31, 2027 | $1.40 | $1.47 | $1.51 | $1.51 | $1.51 | -7.0% |
Frequently Asked Questions About IOSP
What is the IOSP stock forecast?
Consensus analyst estimates put Innospec's EPS at $5.04 for the fiscal year ending Dec 31, 2026, on revenue of $1.91B. The consensus rating from 3 analysts is Buy.
How do analysts rate IOSP stock?
Of 3 analysts covering Innospec, 1 rates it Strong Buy, 2 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from IOSP next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $5.04, with estimates from $5.00 to $5.08 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $5.97, with estimates from $5.85 to $6.10 from 3 analysts.
What revenue do analysts expect from Innospec next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.91B, with estimates from $1.90B to $1.93B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.02B, with estimates from $2.00B to $2.05B.
How many analysts cover IOSP?
3 analysts rate Innospec stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
IOSP pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors